Clinical Trials Logo

Premature Birth clinical trials

View clinical trials related to Premature Birth.

Filter by:

NCT ID: NCT03504215 Completed - Clinical trials for Prematurity; Extreme

Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health.

Start date: March 2, 2018
Phase: N/A
Study type: Interventional

In spite of advances in neonatal intensive care allowing the first generation survivors of extreme prematurity to now reach young adulthood, these individuals present with reduced exercise capacity; a strong predictor of later chronic disease and mortality. The reason why individuals born preterm have exercise limitation remains unclear and may be a consequence of impact of preterm birth and associated neonatal difficulties on the development of organs important for exercise, namely the lungs, the heart, the vessels (which bring blood and oxygen to the muscles) and the muscles. It is well known that exercise benefits overall health in at-risk as well diseased populations. However, whether exercise training can improve fitness in young adults born preterm was not demonstrated and whether the cardiovascular, pulmonary and muscle impairments associated with preterm birth are reversible through exercise intervention in young adulthood is unknown.

NCT ID: NCT03493113 Completed - Clinical trials for Transient Hypothyroxinemia of Prematurity

EEG Alterations in Preterm Infants With Thyroid Dysfunction

EEG-THOP
Start date: October 2011
Phase:
Study type: Observational

The aim of this study is to investigate differences in electroencephalography (EEG) evolution between preterm infants with and without transient hypothyroxinemia of prematurity (THOP) in order to find differences in the interburst interval and the background pattern and in the maturation of the sleep-wake cycle.

NCT ID: NCT03491826 Completed - Clinical trials for Premature Rupture of Membrane

Fetal and Maternal Outcome in Preterm Premature Rupture of Membranes (PPROM)

Start date: January 2010
Phase:
Study type: Observational

The aim of this study is to compare fetal and maternal outcome in cases of PPROM before 34 weeks versus after 34 weeks.

NCT ID: NCT03480139 Completed - Pregnancy Clinical Trials

Biomarkers in Obstetrical Complications

Start date: February 28, 2018
Phase:
Study type: Observational

Objective: To study the natural history of normal pregnancy and the most frequent pregnancy complications responsible for the excessive rate of perinatal morbidity and mortality, in order to develop models to predict the occurrence of these complications of pregnancy at the earliest possible time. The study focuses on the prediction of preterm labor with intact membranes, preterm prelabor rupture of membranes (PROM), preeclampsia, small for gestational age, gestational diabetes, and fetal death. These complications account for a minimum of $30 billion annually in the US alone. Study population: A cohort of pregnant women seeking care at the prenatal clinic of the Perinatology Research Branch in Detroit, Michigan. Design: A prospective observational cohort study of the natural history of women with a normal pregnancy, a history of adverse outcome, or those with a complication in the index pregnancy; therefore, this study will include nulliparous and parous women. Data will be collected at the time of clinic visits and will include interviews, clinical measurements, and ultrasound studies. We will assemble a biorepository of maternal biological fluids (blood, urine, saliva, cervicovaginal fluid, gingival crevicular fluid, swabs to characterize microbiota, amniotic fluid when a clinically indicated amniocentesis is performed). Placentas will be collected at the time of delivery as well as umbilical blood, and swabs to characterize the neonatal microbiota. We will use a retrospective case control and case-cohort design to generate models for the prediction of the most common pregnancy complications. These models will be developed by classifying obstetrical complications according to clinical presentation and histologic placental lesions. Models will be developed and subsequently validated in an independent cohort. Outcome measures: The goal is to develop sensitive, specific, and parsimonious predictive models to identify the patients at risk for developing complications of pregnancy using a combination of clinical and biological markers (biochemical and biophysical).

NCT ID: NCT03473210 Completed - Clinical trials for Preterm Premature Rupture of Membrane

The Value of Amniopatch in Preterm Premature Rupture of Membranes

Start date: October 1, 2016
Phase: N/A
Study type: Interventional

A randomized controlled trial that involved 100 women diagnosed with PPROM between 24 and 34 weeks of gestational age. Participants were randomized equally into 2 groups. Group I in which amniopatch was done (an amnioinfusion of platelet concentrate followed by fresh frozen plasma in addition to the routine management used in the control group. Group II were treated with routine management including antibiotics and corticosteroids

NCT ID: NCT03464396 Completed - Clinical trials for Respiratory Control in Premature Infants

Prematurity-Related Ventilatory Control

PreVent
Start date: May 14, 2018
Phase:
Study type: Observational

The purpose of this research study is to improve our understanding of unstable breathing and heart blood flow patterns seen in premature infants. The investigator will use novel non-invasive measures to understand the determinants of these unstable breathing and heart flow patterns to potentially identify new therapies for their prevention.

NCT ID: NCT03459833 Completed - Clinical trials for Premature Ejaculation

Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation

Start date: August 19, 2016
Phase: Phase 3
Study type: Interventional

This randomized controlled cross-over study aims to evaluate the effect and safety of glans penis augmentation using Hyaluronic acid in the treatment of premature ejaculation in compare with placebo .

NCT ID: NCT03447002 Completed - Clinical trials for Premature Ventricular Contraction

Urine Levels of Metanephrin and Normetanephrin in Patients With Frequent Ventricular Premature Complex

Start date: February 15, 2018
Phase:
Study type: Observational

Enhanced automaticity process is the underlying mechanism for arrhythmias due to excess catecholamines. Catecholamines may increase in patients with PVC. Metabolites of catecholamines are metanephrine and normetanephrine. Our aim is to measure 24 hours urine levels of metanephrine and normetanephrine.

NCT ID: NCT03445689 Completed - Infant,Premature Clinical Trials

Oxygenation Instability and Maturation of Control of Breathing in Premature Infants

Start date: September 4, 2018
Phase:
Study type: Observational

Premature infants present with significant oxygenation instability in the form of frequent spontaneous episodes of hypoxemia during the first weeks after birth. These infants are also exposed to hyperoxemia. The objective of this study is to determine the extent to which exposure to frequent episodes of hypoxemia and hyperoxemia in extreme premature infants during the early stages of their evolving lung disease is associated with altered maturation and function of their respiratory control system. This study is part of the Prematurity-Related Ventilatory Control (Pre-Vent): Role in Respiratory Outcomes Clinical Research Centers (CRC) (U01) cooperative program of the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH).

NCT ID: NCT03440281 Completed - Preterm Labor Clinical Trials

Maternal Serum Homocysteine Levels and Uterine Artery Pulsatility Indices in Preterm Labor

Start date: August 1, 2015
Phase: N/A
Study type: Observational

Study included all pregnant women admitted with threatened preterm labor during the study period. All participants underwent estimation of maternal serum homocysteine level and assessment of uterine artery Doppler indices.